A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Status:
Completed
Trial end date:
2019-03-04
Target enrollment:
Participant gender:
Summary
This is a study to evaluate PF-04449913 (an inhibitor of the Hedgehog pathway) in Acute
Myeloid Leukemia and high-risk Myelodysplastic Syndrome in combination with standard agents
used to treat these diseases.